Detalles de la búsqueda
1.
Outer dynein arm docking complex subunit 2 polymorphism rs7893462 modulates hepatocellular carcinoma susceptibility and can serve as an overall survival biomarker for hepatitis B virus-related hepatocellular carcinoma after hepatectomy: a cohort study with a long-term follow-up.
World J Surg Oncol
; 21(1): 322, 2023 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37833735
2.
Clinical implications and molecular mechanisms of Cyclin-dependent kinases 4 for patients with hepatocellular carcinoma.
BMC Gastroenterol
; 22(1): 77, 2022 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35193513
3.
Role of CCR1/5/7 in hepatocellular carcinoma: a study on prognostic evaluation, molecular subtyping, and association with immune infiltration.
Aging (Albany NY)
; 16(7): 6229-6261, 2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38552222
4.
Sarcosine dehydrogenase as an immune infiltration-associated biomarker for the prognosis of hepatocellular carcinoma.
J Cancer
; 15(1): 149-165, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38164283
5.
Robust analysis of a novel PANoptosis-related prognostic gene signature model for hepatocellular carcinoma immune infiltration and therapeutic response.
Sci Rep
; 13(1): 14519, 2023 09 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37666920
6.
PUS1 May Be a Potential Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma.
Pharmgenomics Pers Med
; 16: 337-355, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37091827
7.
RAD51AP1 as an Immune-Related Prognostic Biomarker and Therapeutic Response Predictor in Hepatocellular Carcinoma.
Int J Gen Med
; 16: 4377-4392, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37789880
8.
Case report: hepatic arterial infusion chemotherapy combined with sintilimab and lenvatinib for conversion therapy of colorectal cancer liver metastases.
Front Immunol
; 14: 1325445, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38173715
9.
Case Report: A case of hepatocellular carcinoma with aberrant right hepatic artery treated with transarterial chemoembolization and infusion chemotherapy separately to bilobar lesion combining with systemic therapies and sequential hepatectomy.
Front Oncol
; 13: 1165538, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37469401
10.
A novel Peng's test in reducing bile leakage after partial hepatectomy for hepatocellular carcinoma: From an animal study to a clinical cohort Propensity score matching comparative study.
Int J Surg
; 104: 106748, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35798204
11.
High-Mobility Group AT-Hook 1 Served as a Prognosis Biomarker and Associated with Immune Infiltrate in Hepatocellular Carcinoma.
Int J Gen Med
; 15: 609-621, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35058711
Resultados
1 -
11
de 11
1
Próxima >
>>